Genesis Therapeutics

Curated by Signal

Developer of computational platform for drug discovery using AI

Overview

Genesis Therapeutics develops a computational platform for the discovery of small molecule drug-using AI. The company uses neural networks, biophysical simulation, and scalable computing platform for the design and development of drugs.

Key facts

Founded: 2019
Headquarters: San Francisco, United States
Stage: Sign up to view
Industry: Health Technology

Business model

2 products and services: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Microtella
Provider of smartwatch for tracking fitness activities
Health TechnologyWilmington, United States
Ondello
Telehealth platform
Health TechnologySan Francisco, United States
A Place for Mom
Marketplace of senior living facilities and other elderly care services
Health TechnologySeattle, United States

About Genesis Therapeutics

What does Genesis Therapeutics do?

Genesis Therapeutics develops a computational platform for the discovery of small molecule drug-using AI.

Where is Genesis Therapeutics headquartered?

Genesis Therapeutics is headquartered in San Francisco, United States.

When was Genesis Therapeutics founded?

Genesis Therapeutics was founded in 2019.

Which sector is Genesis Therapeutics in?

Genesis Therapeutics operates in Health Technology.

Who are Genesis Therapeutics's competitors?

Companies similar to Genesis Therapeutics include Microtella, Ondello, and A Place for Mom.